Nucleic Acid Isolation and Purification Market worth $9.4 billion by 2028 - Exclusive Report by MarketsandMarkets™

 Factors responsible for the growth of this market include technological advancements, growing research & development activities, and growing automation. Opportunities such as emerging economies are expected to drive the market.

The report "Nucleic Acid Isolation and Purification Market  is projected to reach USD 9.4 billion by 2028 from USD 6.4 billion in 2023, at a CAGR of 8.1% during the forecast period.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=229978287

 

Market Segmentation: -

Based on products, the nucleic acid isolation and purification market has been segmented into kits, reagents, and instruments. The instruments segment is further segmented into automatic and manual instruments. In 2022, the kits segment accounted for the largest share of the global nucleic acid isolation and purification market. Factors driving the market growth include benefits of kits such as price and ease of usage in molecular biology techniques.

Based on type, the global nucleic acid isolation and purification market is segmented into circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, plasmid DNA isolation and purification, total RNA isolation and purification, and other nucleic acid isolation and purification types. In 2022, the plasmid DNA isolation segment accounted for the largest share of the market. The segment is driven by factors such as growing wide usage of purified plasmid DNA and increasing application in gene expression profiling, in various downstream applications.

Based on method, the global nucleic acid isolation and purification market is segmented into magnetic bead-based isolation and purification, reagent-based isolation and purification, column-based isolation and purification, and other methods. In 2022, magnetic bead-based isolation and purification method accounted for the highest share due to benefit of using magnetic beads is the ability of isolating nucleic acids and other biomolecules directly from crude samples, and from diverse types of samples, without much processing.

Based on application, the global nucleic acid isolation and purification market is segmented into agriculture & animal research, diagnostics, drug discovery & development, personalized medicine, and other applications. In 2022, the diagnostics segment held the largest share of the global nucleic acid isolation and purification market. Key factors driving market growth include the expanding use of nucleic acid isolation in pathogen identification, increasing patient awareness of genomic diagnostics, and the rising efficiency of genomics sequencing for disease diagnosis.

Regional Analysis:

The nucleic acid isolation and purification market is broadly divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is the fastest growing and most dynamic market in the world and is estimated to be the most attractive regional market nucleic acid isolation and purification market. Countries such as China, India, and Japan are expected to witness high growth in the market for nucleic acid isolation and purification because of the large population in these countries. Also, due to rising health concerns, higher incomes, and better government initiatives, the pharmaceutical market in this region is projected to grow. Together, these factors fuel the growth of the nucleic acid isolation and purification market in the Asia Pacific region.

Recent Developments of Nucleic Acid Isolation and Purification Industry

• In August 2023, Danaher Corporation entered into a definitive agreement to acquire all the outstanding shares of Abcam. Through this development, Abcam is expected to operate as a standalone operating company within Danaher’s Life Sciences segment.
• In July 2023, INOVIQ and Promega announced a global joint marketing agreement for EXO-NET exosome isolation and nucleic acid purification solutions.
• In May 2022, Thermo Fisher partnered with the Qatar Genome Program (QGP), a member of the Qatar Foundation (QF), to accelerate genomic research and clinical applications of predictive genomics in Qatar.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=229978287

 

Top Key Players:

Key players in the nucleic acid isolation and purification market include, Prominent players in the nucleic acid isolation and purification market are Thermo Fisher Scientific Inc. (US), QIAGEN (Germany), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Promega Corporation (US), Agilent Technologies, Inc. (US), Danaher(US), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), Takara Bio Inc. (Japan), New England Biolabs (US), Abcam Plc (UK), KILPEST India Limited (India), Apical Scientific Sdn. Bhd. (Malaysia), Endress+Hauser Group Services AG (Switzerland), GENAXXON bioscience GmbH (Germany), LGC Biosearch Technologies (US), Zymo Research Corporation (US), Norgen Biotek Corp. (Canada), Omega Bio-Tek, Inc. (US), FAVORGEN Biotech Corp. (China), TIANGEN Biotech (Beijing) Co., Ltd. (China), AutoGen Inc. (US), PCR Biosystems (UK), and Biogenuix (India).

 

Animal Wound Care Market Trends: Insights into a Growing Industry

 The growth in the Animal Wound Care Market is driven by rising demand for animal food products, increasing companion animal market, and surging veterinary healthcare expenditure. However, an upsurge in pet care expenditures and the dearth of vet practitioners in developing markets are impeding the market's growth.

Animal Wound Care Market is projected to grow from USD 1.2 billion in 2022 to USD 1.7 billion by 2027, at a CAGR of 7.3% from 2022 to 2027, according to a new report by MarketsandMarkets™. 

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=253831778

KEY MARKET DYNAMICS: IMPACT ANALYSIS

           1 DRIVERS

                    1.1 Growing population of companion animals

                    1.2 Rising demand for pet insurance and growing animal health expenditure

                    1.3 Increasing number of veterinary practitioners and rising income levels in developed economies      

                    1.4 Rising demand for animal-derived food products        

                    1.5 Increasing prevalence of diseases

           2 OPPORTUNITIES

                    2.1 Untapped emerging markets

           3 CHALLENGES

                    3.1 Lack of animal health awareness in emerging countries

                    3.2 Shortage of veterinary practitioners in developing markets

Market Segmentation: - 

·         In this report, the animal wound care market is segmented on the basis of product, animal type, end users and region.

·         In 2021, companion animals for a larger share of the global market. The growth of this segment can be attributed to the growing companion animal population, increasing pet care expenditure, the rising number of sports horses, and surging demand for pet

·         On the basis of end users, the market is segmented into veterinary hospitals and clinics and home care settings. The large share of this segment can be attributed to increasing companion animal population and rising pet care expenditure in emerging regions.

Request Sample Pages: 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=253831778

Regional Analysis: -

On the basis of region, the animal wound care market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East Africa. North America segment accounted for the largest share of the market in 2021 due to major players availability and advanced healthcare infrastructure.

Recent Developments

• In April 2022, Elanco and Ginkgo Bioworks launch BiomEdit, a new animal health company leveraging microbiome technology.
• April 2020, Elanco and VetNOW collaborated to expand their access to veterinary care and provide relief to animal owners from the impact of COVID-19.

Key Market Players:

The prominent players in the global animal wound care market are Medtronic PLC (Ireland), Elanco Animal Health (US), Virbac (France), B. Braun Melsungen AG (Germany), Dechra Pharmaceuticals (UK), Neogen Corporation (US), Jorgen Kruuse A/S (Denmark), Ethicon, Inc. (US), Sonoma Pharmaceuticals Inc. (US), Prima-Vet Inc. (US), Smith & Nephew PLC (UK), Jazz Medical, LLC (Ireland), Kericure Inc. (US), etc.

In conclusion, the animal wound care market's growth and dynamics are shaped by a combination of regional factors, including pet ownership trends, agricultural practices, economic conditions, regulatory frameworks, and veterinary healthcare infrastructure. Understanding these regional nuances is crucial for industry stakeholders to tailor their strategies and offerings to effectively meet the diverse needs of animal owners and caregivers across the world.

Key Players in the Breast Biopsy Devices Market: A Competitive Analysis

 The major factors driving the growth of Breast Biopsy Devices Market include the growing prevalent cases of breast cancer, the increasing number of breast cancer screening programs, the growing demand for minimally invasive and non-invasive procedures, and the improved reimbursement scenario.

What the Market Looks Like?

Breast Biopsy Devices Market  is projected to reach USD 2.6 billion by 2028 from USD 1.6 billion in 2023, at a CAGR of 10.0% from 2023 to 2028.

Download  PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=189011805

Market Segmentation: -

Based on the type, the global breast biopsy devices market is segmented into biopsy needles, guidance systems, localization wires, assay kits, liquid biopsy instruments, biopsy tables, and other devices. The assay kits segment is expected to grow at the highest CAGR during the forecast period.

Based on the procedure, the breast biopsy devices market is segmented into needle open surgical breast biopsy, breast biopsy, and liquid breast. The liquid breast biopsy segment is anticipated to register the highest growth rate over the forecast period.

Based on application, the market is segmented into early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring. Early cancer screening accounted for the largest share of the market in 2022. However, the therapy selection segment is expected to grow at the highest CAGR during the forecast period.

Based on the end user, the breast biopsy devices market is segmented into hospitals & surgical centers, breast care centers, and imaging clinics & diagnostic centers. The hospitals & surgical centers segment accounts for the largest share of the market in 2022.

What Drives the Market?

The growth of the global market for Breast Biopsy is primarily influenced by the following factors:

1 Growing incidence of breast cancer
2 Increasing number of breast cancer screening programs
3 Increasing demand for minimally invasive and non-invasive procedures
4 Growing awareness regarding early detection of breast cancer
5 Improved reimbursement scenario.

Regional Analysis: -

The North American breast biopsy devices market is estimated to grow significantly from 2023 to 2028. factors such as ongoing technological advancements, rising breast cancer incidence rates, favorable reimbursement scenarios, and new breast density notification laws drive market growth in North America. This region has a rise in healthcare investment and expenditure, offering significant growth opportunities for the key players.

 

Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=189011805

Recent Developments:

• Hologic, Inc, an innovative medical technology company primarily focused on improving women’s health, announced today that it has completed the purchase of SOMATEX Medical Technologies GmbH; the deal size is $64 million.
• In 2022 Danaher Corporation launched Mammotome Revolve EX Dual Vacuum-Assisted Breast Biopsy System, the first vacuum-assisted biopsy device designed specifically for the excision of benign breast lesions and is twice as fast as traditional vacuum-assisted breast biopsy systems.
• Argon Medical Devices announced the launch of the SuperCore advantage semi-automatic biopsy instrument’s newest addition to its soft tissue biopsy product portfolio in the united states. The next-generation soft tissue biopsy instrument provides a superior volume of tissue samples. Collecting more tissue volume may increase the likelihood of an accurate diagnosis.

Top Key Players: -

As of 2022, prominent players in the breast biopsy devices market are Hologic Inc. (US), Danaher Corporation (US), Argon Medical Devices (US), Medtronic (IRL), Merit Medical Systems (US), Menarini-Silicon Biosystems (ITL),  Varian Medical Systems, Inc. (Germany), Planmed Oy (Finland), Sterylab S.R.L (Italy), Biocept, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Qiagen (Germany) and Exact Sciences Corporation (US).

The breast biopsy devices market is highly competitive, with several key players globally. Market dynamics, such as technological advancements, regulatory changes, and the evolving healthcare landscape, can impact the growth and development of this market.

Label-free Detection Market worth $863 million by 2028, growing at a CAGR of 8.7%

 The growth of Label-free Detection Market is driven by rising prevalence of target diseases and disorders, the availability of funding for life science research and development, effectiveness of label-free technology in drug discovery. Additionally, the technological advancement in label-free detection leading to expanded applications and adoption of label-free detection products.

The report Label-free Detection Market  is projected to reach USD 863 million by 2028 from USD 570 million in 2023, at a CAGR of 8.7% during the forecast period of 2023 to 2028.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32435593

Key Market Dynamics:

          1 DRIVERS

                   1.1 Technological advancements in label-free detection

                   1.2 Growing academic-industrial partnerships for drug discovery programs

                   1.3 High sensitivity of label-free technologies

           2 RESTRAINTS

                   2.1 High cost of instruments

           3 OPPORTUNITIES

                   3.1 Growing life sciences research in emerging economies

           4 CHALLENGES

                   4.1 Sample complexity and interference

           5 TRENDS

                   5.1 Rising pharmaceutical outsourcing.

                   5.2 Increasing applications of label-free electrochemical sensing platforms

 

Market Segmentation: -

By type, the label-free detection market has been further categorized as instruments, consumables, and software & services. The instrument segment held the largest share of the global label-free detection market in 2022.

Based on technology, the global label-free detection market has been segmented into surface plasmon resonance, differential scanning calorimetry, bio-layer interferometry, isothermal titration calorimetry, and other label-free detection technologies. The surface plasmon resonance segment held the largest market share in 2022.

Regional Analysis:

The label-free detection market in North America has experienced significant growth in recent years, showcasing a robust expansion trajectory, owing to the well-established research infrastructure, strong pharmaceutical and biotech industry, increasing government support for life science research, technological advancements in label-free technologies, and collaborative initiatives contribute to the growth of the label-free detection market in the North America region.

Recent Developments of Label Free Detection Industry

• In April 2022, Sartorius launched the new Octet SF3, the first SPR system under the Sartorius Octet brand. Octet SF3 is a next-generation SPR instrument that offers robust, high-throughput, low maintenance characterization of biomolecular interactions.
• In February 2021, Creoptix, a subsidiary of Malvern Panalytical, launched WaveRAPID, a new and faster way of measuring kinetics to accelerate drug discovery.

Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=32435593

Top Key Players: -

Key players in the label-free detection market include Danaher (US), Sartorius AG (Germany), Waters Corporation (US), PerkinElmer, Inc. (US), AMETEK, Inc. (US), HORIBA, Ltd. (Japan), Spectris (UK), METTLER TOLEDO International Inc., (US), Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), Hitachi High-Tech Corporation (Japan), Attana AB (Sweden), Bruker (US), NanoTemper Technologies GmbH (Germany), Affinité Instruments (Canada), Biosensing Instrument (US), Unchained Labs (US), BioNavis Ltd. (Finland), Carterra, Inc. (US), Nicoya (Canada), BiOptix Analytical LLC (US), Plexera Bioscience (US), XanTec Bioanalytics GmbH (Germany), lino Biotech AG (Switzerland), and KEP Technologies (France).

The label-free detection market is influenced by factors such as advancements in technology, increasing drug discovery efforts, growing investment in life sciences research, and the need for more accurate and direct measurement of biomolecular interactions. 

Digital X-ray Market: Technological advancements and product development

 The major factors driving the growth of Digital X-ray Market include the increasing geriatric population and growth in disease incidence as well as favorable government regulations, investments, and initiatives. The advantages of digital X-ray systems have played a key part in their adoption; their speed and accuracy, as well as quick processing times, allow for significantly higher patient screening volumes than earlier. This has pushed companies to focus on product development and innovation.

The global digital X-ray market is expected to reach USD 16.4 billion by 2026 from an estimated USD 11.1 billion in 2021, at a CAGR of 8.1% from 2021 to 2026.

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1164

Market Segmentation: -

·         Based on technology, the market is segmented into direct radiography and computed radiography. The direct radiography segment commanded the largest share of the global market in 2020.

·         Based on portability, the digital X-ray market is segmented into fixed digital X-ray systems and portable digital X-ray systems. Fixed digital X-ray systems include floor-to-ceiling-mounted systems and ceiling-mounted systems, while portable digital X-ray systems include mobile X-ray systems and handheld X-ray systems.

·         The global digital X-ray systems market is divided into new and retrofit digital X-ray systems. The retrofit digital X-ray systems segment is expected to dominate the market during the forecast period.

·         Based on end users, the X-ray market is segmented into diagnostic centers, hospitals, and dental care centers. Hospitals are expected to dominate the market during the forecast period.

·         Based on applications, the market is segmented into general radiography, dental applications, fluoroscopy, cancer, and mammography applications. The general radiography segment is expected to dominate this market during the forecast period

Regional Analysis: -

The digital X-ray market is segmented into five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is the largest regional market for digital X-ray systems, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.

Request Sample Pages :-https://www.marketsandmarkets.com/requestsampleNew.asp?id=1164

Recent Developments:-

• In March 2021, Koninklijke Philips N.V. (Netherlands) received US FDA 510(k) clearance for CombiDiagnost R90, a high-end digital radiography-based fluoroscopy system
• In August 2020, GE Healthcare (US) received FDA 510(k) clearance for Pristina Serena Bright, a contrast-enhanced mammography solution for biopsy
• In November 2018, Siemens Healthineers (Germany) introduced Multix Impact, a floor-mounted radiography system, at the Congress of the Radiological Society of North America (RSNA) in Chicago, US

Top Key Players: -

The digital X-ray market is dominated by Siemens Healthineers (Germany), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), FUJIFILM Holdings Corporation (Japan), and Canon, Inc. (Japan). The other leading market players include Carestream Health (US), Shimadzu Corporation (Japan), Hologic Inc. (US), Agfa-Gevaert Group (Belgium), Samsung Medison (South Korea), and Konica Minolta (Japan).

 

High-Throughput Screening (HTS) Market worth $44.5 billion by 2028- Exclusive Report by MarketsandMarkets™

 The global high-throughput screening (HTS) market is expected to grow at a CAGR of 11.6% during the forecast period. The growth of this market is driven by increasing R&D spending in the HTS market. Increased R&D spending can serve as a driving force for the HTS market due to expanded drug discovery efforts, a focus on personalized medicine, technological advancements, and collaborative research efforts.

The report High-Throughput Screening (HTS) Market  is projected to reach USD 44.5 billion by 2028 from USD 25.7 billion in 2023, at a CAGR of 11.6% during the forecast period of 2023 to 2028.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950

Key Market Drivers: -

 

                   1.1 Growing adoption of open innovation models in pharmaceutical & biotechnology companies

                   1.2 Government funding and venture capital investments

                   1.3 Increasing R&D spending

                   1.4 Technological advancements

 

Market Segmentation: -

On the basis type of product & service, the high-throughput screening market is broadly segmented into consumables, instruments, services, and software. In 2022, consumables accounted for the largest share of the high-throughput screening market. This can primarily be attributed to the wide use of reagents & assay kits in HTS techniques, increasing pharmaceutical R&D, and rising government funding for life sciences research.

Based on application, the high-throughput screening market is categorized into drug discovery, biochemical screening, life sciences research, and other applications. The drug discovery application segment accounted for the largest share of the high-throughput screening market in 2022. The key factor driving this segment's growth is the increasing number of clinical trials and rising pharmaceutical R&D expenditure.

Regional Analysis: -

Geographically, the high-throughput screening market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In 2022, North America accounted for the largest share of the high-throughput screening market, followed by Europe and Asia Pacific. The large share of North America in the global market is attributed to the increasing prevalence of diseases, rising pharmaceutical R&D expenditure, and the presence of major players in the region are factors driving the growth of the HTS market in this region.

Market Opportunity: -

Emerging markets like China, India, and Brazil have experienced rapid expansion in the life science and biotechnology sectors in recent years. These regions have a significant pool of talented researchers, physicians, and scientists who are actively pursuing research in these fields. Additionally, government initiatives in emerging markets play a crucial role in promoting the adoption and development of HTS technologies. Governments can establish regulatory frameworks and guidelines to ensure the safe and ethical use of HTS technologies.

Recent Developments of High Throughput Screening Industry

• In February 2023, Agilent Technologies, Inc. launched the on-deck thermal cycler that integrates with the Agilent Bravo NGS automated liquid handling platform.
• In February 2023, PerkinElmer Inc. launched the Multimode Plate Reader for high-throughput screening (HTS) applications and to accelerate drug discovery efforts.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=134981950

Top Key Players: -

Key players in the high-throughput screening (HTS) market include Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), PerkinElmer, Inc. (US), Tecan Trading AG (Switzerland), AXXAM S.p.A (Italy), Promega Corporation (US), Bio-Rad Laboratories, Inc.(US), Promega Corporation (US), Hamilton Company (US), Corning Incorporated (US), Charles River Laboratories (US), Lonza (Switzerland), REPROCELL Inc. (Japan), Aurora Biomed (Canada), BMG LABTECH (Germany), DIANA Biotechnologies, s.r.o. (Czech Republic), NanoTemper Technologies GmbH (Germany), Creative Biolabs (US), Biomat Srl (Italy), HighRes Biosolutions (US), Cyclica Inc. (Canada), Crown Bioscience (US), and Sygnature Discovery (UK).